BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

VBI Vaccines’ Fight Against Hep B Expands Globally

Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri in the Asia Pacific region VBI will rece...

July 06, 2023 | News

Meissa Vaccines Signs CGMP Manufacturing Agreement for Pediatric RSV Vaccine in Phase 2 Trials

Under the agreement, Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under Current Good Manufacturing Practice (CGMP) regulations to ...

July 06, 2023 | News

Brii Biosciences Expands Hepatitis B Leadership with Comprehensive Portfolio from Prevention to Cure

Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...

July 06, 2023 | News

SK Bioscience and Government Pharmaceutical Organization Strengthen Vaccine Infrastructure in Thailand

SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...

July 05, 2023 | News

SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...

June 27, 2023 | News

SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization

In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 parental strain and had a standard safety and reactogen...

June 19, 2023 | News

Novavax Set to Deliver Protein-based Monovalent XBB COVID Vaccine as per FDA VRBPAC Recommendation in Fall

Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale w...

June 16, 2023 | News

China Approves World's First Vaccine for XBB Descendent Lineages of SARS-CoV-2

WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...

June 12, 2023 | News

YS Biopharma's PIKA Rabies Vaccine Approved for Phase 3 Clinical Trials by Philippines FDA

The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...

June 02, 2023 | News

Thermo Fisher Scientific Expands Sterile Drug Facility in Singapore, Strengthening Asia-Pacific BioPharma Market

Thermo Fisher Scientific, a global leader in serving science, announces the expansion of its sterile drug facility in Singapore, marking a significant mile...

June 02, 2023 | Influencers

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...

May 31, 2023 | News

Luzhu Biotechnology's LZ901 Completes Phase II Clinical Trial for Herpes Zoster Vaccine

Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a l...

May 31, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

May 24, 2023 | News

Stay Connected